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Objective: To examine whether parity or gravidity contributes to the development of the metabolic 
syndrome (MS). 
Methods: The first phase of the Guangzhou Biobank Cohort Study recruited 7352 women and 3065 
men aged 50 to 93 years in 2003-4. Data on the number of live births and pregnancies, and other 
reproduction associated factors, socioeconomic and lifestyles factors were collected by standardized 
interview. The MS components were determined through physical examination and measurement of 
fasting blood samples. MS was identified if waist circumferences were ≥90cm for men, or ≥80cm 
for women, plus any two of: a) raised TG level: 1.7 mmol/L, or specific treatment for this lipid 
abnormality; b) reduced HDL-cholesterol: <1.03 mmol/L in males or <1.29 mmol/L in females, or 
specific treatment for this lipid abnormality; c) raised blood pressure: systolic or diastolic blood 
pressure ≥130 or ≥85 mm Hg, or hypertension therapy; d) raised fasting glucose ≥5.6 mmol/L, or 
previously diagnosed Type 2 diabetes. 
Results: Before adjustment for potential confounders, there were associations between the number 
of births and lifestyle and socioeconomic factors in both sexes. However, in women, but not in men, 
BMI, waist-hip ratio, triglyceride and glucose were positively associated with the number of birth 
after adjusting for a range of potential confounders. The age-adjusted prevalent MS increased with 
the higher number of birth and pregnancy in women, but the gradient for birth was steeper than that 
for pregnancies [odds ratio change per birth: 1.16 (95% CI: 1.11-1.22), p<0.001; odds ratio change 
per pregnancy: 1.11 (95% CI: 1.06-1.16), p<0.001], although attenuating the associations 
adjustment did not affect the significance of these findings. There was no association in men for the 
number of their partners’ live births given the same analysis and similar shared living background 
with the women. 
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Conclusion: Higher parity or gravidity was associated with a consistent increase in the risk of MS 
in Chinese women.  As the association persisted after adjustment for lifestyle factors and there was 
no association between the risk of MS and the number of births associated with the partners of the 
males, the association in women may represent a biological response to pregnancy. 
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Introduction 
The dramatic alterations in the hormonal milieu and body morphology during pregnancy among 
women, and other concomitant changes, may have detrimental effects on the body, promoting 
increases in the vascular risk factors associated with the metabolic syndrome (MS) in later life, 
including weight gain, increased blood pressure, insulin resistance, and dyslipidemia. 1-8 Additional 
pregnancies, socioeconomic status, and lifestyle factors may also influence development of these 
risk factors.9,10 By examining the effects of live births in women and those associated with the 
partners of the men, we aimed to establish whether parity or gravidity is associated with the 
development of the metabolic syndrome (MS).   
 
Methods 
Guangzhou Biobank Cohort Study 
The Guangzhou Biobank Cohort Study is a collaboration between the Guangzhou Number 12 
Hospital, Guangzhou, China and, the Universities of Hong Kong, Hong Kong and Birmingham, UK. 
We plan to recruit about 30,000 older participants aged 50 or above from 2003-2007 and to follow 
them up to examine environmental and genetic determinants of common chronic diseases in an 
older southern Chinese population. The hospital where the study is conducted has all the facilities of 
a general medium-sized hospital and an infrastructure for occupational health surveillance for 
workers of many factories and employees of some service industry.  Guangzhou is the major city 
in southern China with a population of 7.25 million. 
 In developing countries such as China, the infrastructure，such as a client registration list of 
family physician, to facilitate cohort studies is not available. However, a community social and 
welfare association, “The Guangzhou Health and Happiness Association for the Respectable 
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Elders”, aligned with the Guangzhou government was chosen as a sampling frame, because it is a 
large association with branches throughout Guangzhou and its membership is open to anyone for a 
nominal, discretionary fee of 48 Yuan (US$ 6) per month.  It has a city-wide network with around 
100,000 members, approximately 9% of the Guangzhou older population.  
 The male and female participants were randomly recruited from the association’s membership 
list of eligible subjects.  About 5% of eligible subjects refused to participate, with less than 1% of 
females, and about 10% of males refusing.  The males generally refused because of a cultural 
unwillingness of Chinese males to give blood due to the belief in an associated loss of ‘shung qi’ or 
‘life energy’, and because of job commitments.  There were also more women than men in the 
older population due to the longer life expectancy.  Generally however most of the subjects were 
keen to participate as they could receive free health examinations.  We only included those who 
were ambulatory, and not receiving treatment modalities which if omitted may result in immediate 
life threatening risk, such as chemotherapy or radiotherapy for cancer, and dialysis for renal failure.  
Those with less immediate risk, such as those with a history of vascular disease or associated risk 
factors including diabetes and hypertension were not excluded from the study.  The first phase 
10417 participants were recruited during 2003-4.  The study has received ethical approval from the 
Guangzhou Medical Ethics Committee of the Chinese Medical Association, Guangzhou, China.  
All participants gave written, informed consent prior to participating in the study.   
 
Measurements  
Six full time trained nurses interviewed the participants, with all questions being computerized and 
the information collected and entered directly into the computer. Parity refers to the number of 
biological live births for women and, for men refers to their children, i.e. to the live births of their 
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partners. Gravidity is defined as the number of pregnancies, including lost pregnancies and still 
births. Information on other reproduction associated factors (age at menarche, age at menopause, 
age at first pregnancy, history of miscarriage, pregnancy terminations, breast feeding, and use of 
contraceptive pills or hormone therapy) was collected in the women. In addition, information on 
socioeconomic factors (education, occupation, household income), lifestyle factors (smoking, 
alcohol drinking, physical activity) was collected.  
 Participant recruitment began on September 1, 2003. In June 2004, with 200 randomly selected 
participants were invited back to the hospital and re-interviewed with the same questionnaire for 
validation. We used the kappa value and Intraclass Correlation Coefficient (ICC) to assess the 
reliability for categorical and continuous variables respectively. The kappa values of parity and 
gravidity were 0.93 and 0.79 respectively. The kappa values for other categorical variables involved 
in this paper were: smoking (0.96 and 0.88 for the two questions on smoking status), drinking 
(0.60), physical activity (0.58), education (0.90), occupation (0.80), household income (0.60), and 
use of contraceptive pills (0.67), and the ICC for continuous variables were: age at menarche (0.92), 
age at menopause (0.70) and age at first pregnancy (0.50). 
 Seated blood pressure was measured three times, one minute apart, after a 3 minute rest, using 
the Omron 705CP sphygmomanometer. The average of the last two readings was used in the 
analysis.  Weight and height were measured with light indoor clothing and without shoes. Body 
mass index (BMI) was calculated as the weight in kilogram (kg) divided by the square of height in 
meters. Waist circumference was measured horizontally around the smallest circumference between 
the ribs and iliac crest. For obese participants with no natural waistline, waist circumference was 
measure at the level of the navel. Hip circumference was taken around the maximal girth of the hips.  
Total serum cholesterol, LDL-, and HDL-cholesterol, triglycerides (TG), and glucose levels were 
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determined by Shimadzu CL-8000 Automatic Chemical Analyzer in the hospital laboratory. Blood 
samples were drawn using a vacutainer tube in the morning after an overnight fast. The interview 
and all examinations above were conducted in Guangzhou No. 12 Hospital according to the 
“Guangzhou Biobank Cohort Study” standard operating procedures prepared by the collaborators.  
 The International Diabetes Federation (IDF) metabolic syndrome definition (April, 2005) was 
used to diagnose MS.11  Participants were classified as having the MS if their waist circumference 
was ≥90cm for men, or ≥80cm for women, plus any two of the following four factors: a) raised TG 
level: 1.7 mmol/L, or specific treatment for this lipid abnormality; b) reduced HDL-cholesterol: 
<1.03 mmol/L in males or <1.29 mmol/L in females, or specific treatment for this lipid abnormality; 
c) raised blood pressure: systolic BP ≥130 mm Hg, or diastolic BP ≥85 mm Hg, or treatment of 
previously diagnosed hypertension; d) raised fasting plasma glucose ≥5.6 mmol/L, or previously 
diagnosed type 2 diabetes. 
 
Statistical analyses  
ANCOVA was used to compare age-adjusted means of continuous variables. Linear regression was 
used to assess the linear trend. The regression coefficient per unit increase was used to assess the 
change in the dependent variable for 1 live birth or pregnancy. Logistic regression was used to 
estimate odds ratios and adjusted prevalence for dichotomous variables. In the multivariate model, 
adjustments were made for the following variables: age; socioeconomic factors including education 
(no formal school, primary school, junior middle school, senior school, senior technical school, 
university or above), occupation (agriculture & related workers, factory worker, administrator, sales 
& service worker, professional, military/disciplined services, house wife/ husband, unemployed), 
marital status (married, separated/divorced, widowed, never married) and household income (RMB 
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Yuan <5000, 5000-9999, 10000-19999, 20000-29999, 30000-49999, >50000); lifestyle factors 
including smoking status (never, ever), drinking status (never, ever), and moderate physical activity 
(no activity, ≤30 minutes/day, 31-60 minutes/day, ≥60 minutes/day); other reproduction associated 
factors including age at menarche, age at menopause, age at first pregnancy, use of contraceptive 
pills (never, ever).  For the models which included the adjustment of reproduction associated 
factors (age at first pregnancy), the single birth or pregnancy group was treated as the reference 
group instead of zero birth group or zero pregnancy group, because the variable age at first 
pregnancy was not available for most participants in the zero birth group and all participants in the 
zero pregnancy group. Triglyceride and glucose levels were log normally distributed. Their 
geometric means were presented in the tables, and natural log values were used in the regression 
models. Stata 8.2 for Windows was used for all analysis. 
 
Results 
A total of 7352 women and 3065 men aged 50 to 93 years were recruited, of whom 10370 (99.5%) 
had data describing their reproductive history or for males that of their partner(s) included in this 
analysis, and the mean (SD) age was 63.97 (6.04) and 66.19 (5.78) years, respectively. In women, 
the median, and mean (SD) number of births was 3 and, 2.92 (1.37) with a range of 0 to 10 births, 
and the median, and mean number of pregnancies (SD) was 4 and, 4.29 (1.86) with a range of 0 to 
19 pregnancies. In men, the mean (SD) number of live births was 2.64 (1.27) with a range of 0 to 10 
births. The distribution of births for both women and men were similar. Nulliparous women (135) 
constituted 1.84% and no pregnancy group (125) formed 1.66% of women. Thirty nine (1.28%) 
men were childless. 89.07% of women and 85.19% of men had 2 or more children. A total of 2.38% 
of women had never breast fed their children; 24.81% women had miscarriage and 69.92% women 
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had termination of pregnancy; 16.66% women had used contraceptive pills and 33 women had used 
hormone replacement therapy. A total of 2301 (31.62%) women and 475 (15.6%) men were 
diagnosed as having the MS. Prevalences of relevant morbidities, such as hypertension and diabetes, 
were similar to recent, representative samples in China, with hypertension being present in 42.1% 
of men and 43.2% of women aged 55-64 years in the cohort compared with 40.7% and 38.9% in the 
same age group nationally in urban areas.12 Similarly, diabetes was present in 11.9% of men and 
14.7% of women aged 55-64 years in the cohort compared with 12.1% and 12.9% in the same age 
group nationally.13  The demographic characteristics of the participants are shown in table 1. 
 
Socioeconomic and lifestyle factors 
Increasing births were significantly associated with education and occupation (all p values <0.001). 
Participants with primary level education and manual occupation tended to have a greater number 
of births in both women and men (Tables 2 and 3). Similar associations between gravidity and the 
socioeconomic factors were found in the women (data not shown). 
 In women, there was a linear association between the number of births and smoking (p <0.001), 
but no significant association was identified for drinking (p=0.49). Both prevalence of smoking and 
drinking increased with an increasing number of pregnancies (p<0.001 and p=0.004). In men, both 
prevalence of smoking and drinking increased with a higher number of births (p<0.001 and p=0.021 
respectively). Births and pregnancies were not associated with moderate physical activity in either 
gender (Tables 2 and 3). 
 
Reproduction associated factors 
Increasing births were associated with older age of menarche, younger age at first pregnancy, more 
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pregnancy terminations and longer duration of breast feeding (p values range from <0.001 to 0.019), 
but were not associated with age at menopause, miscarriage or use of contraception pills (table 2). 
Gravidity had a strong linear association with all reproduction associated factors (p values ranged 
from <0.001 to 0.0018). 
 
Metabolic syndrome component risk factors 
In women, age-adjusted systolic and diastolic blood pressures had strong linear associations with 
increasing pregnancies and births, but the association was not significant after full adjustment. 
Regarding the risk of obesity, increasing pregnancies and births were associated higher age-adjusted 
BMI, and waist-to-hip ratio (all p<0.001). There was no association between BMI and pregnancy 
after full adjustment, while other associations remained significant. Age-adjusted total, HDL-, 
LDL-cholesterol were negatively and triglycerides were positively associated with pregnancies and 
births (p values ranged from <0.001 to 0.040). Except for triglycerides, the other associations were 
not significant after full adjustment (Tables 2 and 4), whereas age-adjusted fasting glucose was not 
significantly associated with births, but was significant after full adjustment.  In men, only 
age-adjusted mean BMI and systolic blood pressure were associated with the number of births, but 
they disappeared after adjusting for other factors. No significant associations were found between 
other metabolic risk factors and births (Tables 3 and 4).  The age-adjusted means, prevalence of 
MS risk factors and potential confounders by gravidity in women were similar to those described in 
table 2 for parity (data not shown). 
 
Prevalent MS 
The age-adjusted and fully adjusted prevalence of MS by pregnancies and births are shown in figure 
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1. In women, there was an ascending linear trend between pregnancies and births [odds ratio change 
per birth 1.16 (95%CI 1.11-1.22), <0.001] and age-adjusted prevalent MS, but the gradient for 
births was steeper than that for pregnancies [odds ratio change per birth 1.11 (95%CI 1.06-1.16), 
<0.001], which was consistent with those for the other risk factors described above. After 
adjustment for a range of potential confounding factors including age, socioeconomic factors, 
lifestyle and other reproductive factors the odds ratios of prevalent MS for pregnancies and births 
remained significant, as shown in table 4. Even after additional adjustment for BMI, the relationship 
remained significant for both (Table 4 and figure 1).  In men, the relationship between their 
partner’s births and MS was less evident [odds ratio change per birth 1.07 (95%CI 0.97-1.17), 
p=0.16] and was not significant. 
 
Discussion 
To our knowledge, this is the first study assessing the association between prevalent MS and the 
number of live births. We found some consistent associations between pregnancies and births with 
the MS and associated cardiovascular risk factors in Chinese women. Women with a higher number 
of pregnancies and births had a higher prevalence of the MS, with the association of births being 
stronger than that for pregnancy. Adjustment for socioeconomic and lifestyle factors had little effect 
on the odds ratios. As MS components are well documented risk factors for cardiovascular 
disease,14 and people with MS are more likely to develop cardiovascular disease,15-18 our results are 
consistent with most large studies describing the association between births and cardiovascular 
disease.9,10,19,20 
 Most previous studies found a modest relationship between births and BMI, and an increased 
trend of greater upper body fat distribution with an increasing number of births in women.1,3 Our 
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findings are consistent with these results, and show that increasing births results in increased BMI 
and this may, in part, explain the increase in prevalent MS. The extent of the increase in obesity 
with the number of births varies in different ethnic groups, with Lawlor et al reporting that 
age-adjusted BMI increased by 0.36 with per child increase in British women, which is greater than 
that in our women (0.24). Similarly, each live birth in our women was associated with 0.45 kg, 
which was quite similar to that in US women who gained 0.55 kg per live birth.21 However, central 
obesity appeared more closely associated with births in the current study than that in Lawlor’s study 
(waist-hip ratio 0.0063 vs 0.003 per child).9 The associations between births and blood pressure, 
and lipids in our study are consistent with most previous studies.2,4,5,7,8 The relationship between 
births and glucose level is less clear,5,22,23 although in the current study, after adjustment, the 
association was significant. However, weight gain does not account for all the association as even 
after adjustment for BMI, a relationship exists between births and prevalent MS, suggesting 
additional changes may have occurred.  The presence of gestational diabetes or preeclampsia may 
contribute to the development of components of the metabolic syndrome.24 However, data regarding 
the status of these conditions in the subjects during pregnancy are not available. 
 Although we aimed to study the association between pregnancies and births and MS in Chinese 
women, a crucial issue is whether the observed relationship between the syndrome and reproduction 
was due to biological processes initiated by conception, or whether other mechanisms are 
involved,25 such as sociodemographic or lifestyle factors in response to the pregnancy or upbringing 
of children.  Our results showed that lower education and occupation was associated with a greater 
number of pregnancies and births in women and men for the latter. These socioeconomic factors 
were also associated with increased smoking and alcohol consumption, apart from the latter in 
females, which therefore correlated with a higher number of pregnancies and births. However, 
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adjustment for these factors did not change the association between pregnancies and births and the 
MS. It is difficult to discount entirely the role of unmeasured confounding factors. Socioeconomic 
status may not have been adequately controlled for by statistical adjustment for education and 
income.5 The same problems may apply to lifestyle risk factors. We analyzed the data describing the 
men in the same way and found no relationship between births and MS and associated vascular risk 
factors, despite the broadly similar living background shared with the women in the study. The 
women showed greater effect of births than pregnancies on MS. Although births were highly 
correlated with pregnancies, theses two factors are not interchangeable as the latter included 
abortions. The duration of childbearing and the intensity of the hormonal effects of pregnancy 
would be less than that for a completed birth, and may explain the weaker effect of pregnancies on 
MS compared to that for live births. These results strongly suggest that there are some biological 
reproductive effects influencing MS and associated cardiovascular risks which persist in later life in 
Chinese women. The effect was unlikely due to lifestyle or sociodemographic factors.  
 Conclusions drawn from our cross-sectional design may be limited by possible biases. Survival 
bias (if those with a greater number of pregnancies and births had increased risk of premature death) 
would lead to underestimation of the strength of association between pregnancies or births and MS. 
Self-reporting of pregnancies or births could be subject to recall error. Some pregnancy losses are 
clinically unrecognized and not recalled.5 However, live births are more likely to be fully recalled 
than pregnancies. The similarity of the distribution of the number of children for men and women, 
and the similar results by pregnancies and births, suggest that recall error would not have 
substantially biased our results. Our subjects are unlikely to be completely representative of the 
older population of Guangzhou, and in common with any older study population in a developing 
country they are survivors. Thus, caution is needed to infer population prevalences from this study. 
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However investigation of relationships within the study will only be biased if the probability of 
inclusion within the study varies according to the outcome of interest within levels of a predictor, 
which is unlikely, and there is no reason to think that any of these groups would have been more or 
less susceptible to the effects of parity or gravidity on vascular risk factors. Moreover, if 
survivorship were an issue we might expect different relationships in the older than the younger 
subjects, which was not apparent.  The strengths of our study included: a) the large sample size; b) 
the criteria of MS were determined by physical and laboratory measurements and not by 
self-reporting; c) the comparison of MS-pregnancy association with MS-births in women and d) the 
analysis of the birth data in men showing that the result is more likely due to biology than lifestyle. 
 In the present study, the no births and infertility rate were 1.84% and 1.66% respectively in our 
Chinese women, and the childlessness rate in our Chinese men was 1.28%, which are lower than 
those of other populations (3%) with little disease.26 These are consistent with the strong Chinese 
culture preference for marriage and childbearing and the societal stigma associated with 
childlessness, and are supported by Liu et al’s report of primary infertility overall in Chinese being 
1.3%,27 and the 1997 National Population and Reproductive Health Survey which showed that zero 
parity and zero gravidity rates were 2.23% and 1.56% respectively among women (urban) aged 
45-49 years.28  
 We did not include miscarriage, termination of pregnancy and the duration of breast feeding in 
the multivariate model. Obviously increasing pregnancies and births will increase these factors and 
there seems to be no biological mechanisms to suggest that they are associated with the MS. 
Including these variables would result in over adjustment and under-estimation of the association 
between reproduction and the MS and associated cardiovascular risk factors. Further studies to 
examine the effect of lost pregnancy and breast feeding on the MS may be warranted. 
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 In summary, higher pregnancies or births was associated with a consistent increase in the risk 
of MS in Chinese women even after adjustment for a range of potential confounders. As no 
association was found in men between births and the MS, the association with MS in women is 
likely to represent a biological response to pregnancy. Since 1980s, the Chinese government had 
implemented the one child policy strictly and the proportion of single birth women should have 
been increasing quickly. It should be interesting to assess whether such changes in reproduction 
pattern have any effect on the MS in the near future. Moreover, further research on whether parity 
could be an explanation for variation in MS in women and in sex ratio of MS in different 
populations is warranted. 
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 Table 1 Demographic characteristics of the Guangzhou Biobank Cohort Study participants  
 Male (n=3052) Female (n=7318) Total (n=10370) 
 Frequency % Frequency % Frequency % 
Age(years)       
50-59 494 16.2 2242 30.7 2736 26.4
60-69 1713 56.1 3827 52.3 5540 53.4
70+ 845 27.7 1249 17.1 2094 20.2
Education        
No formal school 84 2.7 1246 17.0 1336 12.8
Primary school 891 29.2 2950 40.3 3841 37.0
Junior middle school 882 29.0 1619 22.1 2501 24.1
Senior/ middle technical/ technical 632 20.7 1097 15.0 1729 16.7
Senior technical school / college 261 8.6 233 3.2 494 4.8 
University 301 9.8 173 2.4 474 4.6 
Occupation*        
Agriculture & related workers 145 4.8 926 12.7 1071 10.3
Factory worker 1154 37.8 3619 49.5 4773 46.0
Administrator / manager 882 28.9 917 12.6 1799 17.4
Sales & service workers 548 18.0 847 11.6 1395 13.5
Professional / technical 134 4.4 618 8.4 752 7.3 
Military / disciplined services 69 2.3 7 0.1 76 0.7 
House wife / husband 0 0 74 1.0 74 0.7 
Other 120 3.9 310 4.2 430 4.2 
Marital status       
Married 2821 92.5 5194 71.0 8015 77.3
Separated / divorced 28 0.9 107 1.5 135 1.3 
Widowed 194 6.4 1989 27.2 2183 21.1
Never married 8 0.3 26 0.4 34 0.4 
Household income (Yuan; US$1=8.01Y)       
<5,000 22 1.0 98 2.1 120 1.8 
5,000-9,999 100 4.6 497 10.6 597 8.7 
10,000-19,999 457 20.8 1100 23.4 1557 22.6
20,000-29,999 695 31.7 1275 27.1 1970 28.6
30,000-49,999 535 24.4 1034 21.9 1569 22.8
≥50,000  383 17.5 698 14.8 1081 15.7
Smoking (Ever, %) 1762 57.8 388 5.3 2150 20.7
Drinking (Ever, %) 2193 71.9 2685 36.6 4878 47.0
Moderate activity        
≤30minutes/day 813 26.7 1871 25.5 2684 25.9
31-60 minutes/day 445 14.6 1648 22.5 2093 20.2
≥60 minutes /day 362 11.9 1165 15.9 1527 14.7
Body mass index (kg/m2)       
<18.5 170 5.6 340 4.7 510 4.9 
18.5 ≤BMI <23 1168 38.4 2572 35.2 3740 36.2
23 ≤BMI <25.0 752 24.7 1797 24.6 2549 24.7
≥25.0 943 31.3 2590 35.5 3543 34.3
Central obesity 667 22.5 3695 50.1 4362 42.6
Hypertension 1443 47.5 3486 47.7 4929 47.6
Diabetes 398 13.1 1165 16.0 1563 15.1
Metabolic syndrome§ 475 15.6 2301 31.6 2776 26.9
* Longest held occupation; central obesity: waist circumference was ≥90cm for men, or ≥80cm for 
women; hypertension: systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg 
or drugs for hypertension; diabetes: fasting blood glucose ≥7.0 mmol/L or drugs for diabetes; § IDF 
definition (April, 2005)
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Table 2 Age-adjusted demographic, reproductive parameters, vascular risk factors and components of MS by parity in Chinese women. 
 Number of births 
 0 1 2 3 4 ≥5 
Difference per increase of 
1 birth* P for trend 
n 135 665 2365 2035 1221 897   
Age (years) 65.7(64.8,66.3) 60.1(59.7, 60.5) 61.3(61.1,61.5) 64.5(64.2,64.7) 66.8(66.5,67.1) 68.7(68.4,69.1) 2.1(2.0,2.2) <0.001 
Education (>primary, %) 42.3(34.1,50.9) 68.6(64.8,72.2) 56.1(54.0,58.3) 41.1(38.9,43.2) 22.4(20.1,24.9) 11.9(9.8,14.3) 0.6(0.5,0.6) <0.001 
Occupational (non-manual job, %) 35.9(28.0,44.5) 55.5(51.5,59.5) 45.4(43.2,47.7) 33.5 (31.4,35.6) 22.7(20.4,25.2) 12.4 (10.4,14.8) 0.6 (0.6,0.7) <0.001 
Single/ separated (%) 22.2(15.8,30.3) 1.4 (0.8,2.4) 1.5(1.1,2.0) 0.9 (0.6,1.4) 1.0(0.6,1.8) 1.5(0.9,2.8) 0.6(0.5,0.7) <0.001 
Smoking status (ever, %) 4.1 (1.9,8.5) 2.2(1.3, 3.9) 3.7(2.9,4.6) 4.8(3.9,5.8) 5.9(4.7,7.3) 8.0(6.4,9.9) 1.3(1.2,1.4) <0.001 
Drinking status (ever, %) 34.6(27.1, 43.0) 37.9(34.3,41.6) 36.6(34.7,38.6) 36.8(34.7,38.9) 35.0(32.3,37.8) 35.2(32.1,38.4) 1.0(1.0,1.1) 0.49 
Moderate activity (%) 54.9(46.4, 63.2) 65.5(61.7,69.1) 65.2(63.1,67.2) 64.5 (62.4,66.5) 63.5(60.7,66.2) 61.3(58.0,64.6) 1.0(0.9,1.0) 0.35 
Systolic blood pressure (mm Hg) 133(129,137) 131(130,133) 132(131,133) 133(132,134) 134(133,135) 137(135,138) 1.0(0.5,1.4) 0.001 
Diastolic blood pressure (mm Hg) 74(72,75) 72(72,73) 73(73, 74) 74(73, 74) 74(74, 75) 76(75, 77) 0.6(0.4,0.9) <0.001 
Body mass index (kg/m2) 23.3(22.7,23.8) 23.4(23.1,23.7) 23.8(23.6,23.9) 24.0(23.9,24.2) 24.3(24.1,24.5) 24.3(24.1,24.6) 0.2(0.2,0.3) <0.001 
Waist-to-hip ratio 0.86(0.85,0.87) 0.85(0.85,0.86) 0.86(0.86,0.86) 0.87(0.86,0.87) 0.88(0.87,0.88) 0.88(0.87,0.88) 0.0063(0.0049,0.0076) <0.001 
Weight gain since 18 years (kg) 9.3(7.9,10.7) 9.9(9.3,10.6) 10.7(10.4,11.1) 11.0(10.7,11.4) 11.6(11.2,12.1) 11.7(11.2,12.3) 0.45(0.3,0.6) <0.001 
Total cholesterol (mmol/L) 6.05(5.61,6.49) 6.31(6.10,6.51) 5.98(5.87,6.09) 5.92(5.81,6.04) 5.92(5.77,6.07) 5.93(5.75,6.10) -0.058(-0.11,-0.0039) 0.036 
Triglyceride (mmol/L) † 1.35(1.25,1.48) 1.39(1.32,1.45) 1.42(1.39,1.45) 1.48(1.45,1.51) 1.48(1.43,1.52) 1.51(1.45,1.55) 0.020(0.0098,0.031) <0.001 
HDL-cholesterol (mmol/L) 1.77(1.71,1.83) 1.74(1.71,1.77) 1.75(1.73,1.76) 1.72(1.71,1.74) 1.72(1.70,1.74) 1.72(1.69,1.74) -0.0085(-0.016,-0.0013) 0.021 
LDL-cholesterol (mmol/L) 3.13(3.01,3.24) 3.09(3.04,3.14) 3.09(3.03,3.09) 3.06(3.03,3.09) 3.05(3.01,3.09) 3.03(2.98,3.07) -0.018(-0.032,-0.0044) 0.0093 
Glucose (mmol/L) † 5.87(5.64,6.11) 5.93(5.81,5.99) 5.87(5.81,5.99) 5.93(5.87,5.99) 5.93(5.87,6.05) 5.99(5.87,6.11) 0.0040(-0.00085,0.0089) 0.11 
Age at menarche (yrs) 15.4(15.1,15.8) 15.0(14.8,15.1) 14.9(14.8,15.0) 15.5(15.4,15.6) 15.8(15.7,15.9) 16.0(15.9,16.2) 0.3(0.3,0.3) <0.001 
Age at menopause (yrs) 48.6(47.9,49.3) 48.9(48.6,49.2) 49.4(49.2,49.6) 49.2(49.0,49.4) 49.5(49.2,49.7) 49.4(49.2,49.7) 0.1(0.01,0.2) 0.24 
Age at first pregnancy (yrs) 27.6(26.3,28.9) 28.2(28.0,28.5) 25.0(24.8,25.1) 23.4(23.3,23.6) 22.5(22.3,22.7) 21.5(21.3,21.7) -1.45(-1.52,1.38) <0.001 
Miscarriage (ever, %) 59.8(37.7,78.5) 26.59(23.1,30.4) 25.0(23.2,26.9) 23.5(21.7,25.4) 25.8(23.4,8.3) 25.5(22.7,28.5) 1.0(0.9,1.0) 0.57 
Termination of pregnancy (ever %) 14.2(4.6,36.1) 58.5(54.3,62.5) 69.8(67.8,71.8) 73.5(71.5,75.4) 72.0(69.4,74.4) 65.6(62.3,68.7) 1.1(1.0,1.1) 0.019 
Duration of breast feeding 
(months) - 8.3(7.3,9.3) 20.3(19.8,20.8) 33.8(33.3,34.4) 46.9(46.2,47.7) 62.4(61.5,63.3) 13.6(13.3,13.8) <0.001 
Ever use of pills (%) 1.4(0.4, 5.6) 10.2(8.2,12.5) 18.0(16.4,19.7) 16.0(14.5,17.7) 13.9(12.0,16.1) 13.0(10.7,15.6) 1.0(1.0,1.1) 0.43 
Values are means and prevalence (95% confidence intervals). All means, prevalence, regressions coefficients and odds ratios are age-adjusted, except for age. 
*Difference per increase of one birth: for continuous variables, regression coefficients of unit increase in the variables per increase of one birth; for 
dichotomous variables, odds ratio for increase in one birth. † Geometric means presented: regression coefficients represent increase in logged variable per 
increase of one birth. 
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Table 3 Age-adjusted demographic, vascular risk factors and components of MS by parity in Chinese men. 
 Number of births  
 0 1 2 3 4 ≥ 5 Difference per birth increase* P for trend 
n 39 413 1162 797 390 251   
Age (years) 67.3(65.6,68.9) 62.0(61.5,62.5) 64.7(64.4,65.0) 67.8(67.5,69.5) 69.0(68.5,69.5) 70.2(69.6,70.9) 2.0(1.8,2.2) <0.001 
Education (> primary school, %) 53.9(38.3,68.7) 79.6(75.4,83.3) 76.8(74.3,79.1) 67.4(63.9,70.7) 53.4(48.1,58.6) 35.7(29.7,42.1) 0.6(0.6,0.7) <0.001 
Occupation (non-manual job, %)  36.6(22.7,53.3) 59.4(54.3,64.3) 56.0(53.0,59.0) 54.3(50.4,58.1) 41.4(36.2,46.8) 32.3(26.5,38.7) 0.8(0.7,0.9) <0.001 
Single/ separated (%) 20.3(10.3,36.1) 1.7(0.8,3.6) 0.5(0.2,1.1) 1.1(0.6,2.2) 1.3(0.5,3.1) 0.4(0.05,2.80) 0.53(0.38,0.75) <0.001 
Smoking status (ever, %) 65.1(49.1,78.4) 51.2(46.3,56.1) 56.7(53.8,59.5) 61.0(57.4,64.4) 61.8(56.7,66.6) 71.3(65.3,76.6) 1.1(1.1,1.3) <0.001 
Drinking status (ever, %) 55.4(39.8,70.1) 69.7(64.9,74.0) 73.9(71.3,76.3) 73.0(68.6,75.1) 72.2(67.4,76.5) 79.5(74.0,74.1) 1.1(1.0,1.2) 0.021 
Moderate activity (%) 62.9(46.8,76.6) 48.7(43.8,53.7) 53.9(51.1,56.8) 55.3(50.1,60.5) 55.3(50.1,60.5) 48.4(41.9,54.9) 1.0(0.9,1.1) 0.76 
Systolic blood pressure (mm Hg) 137(130,144) 134(132,136) 134(133,136) 135(134, 137) 137(135,139) 138(135,141) 0.98(0.23,1.72) 0.010 
Diastolic blood pressure (mm Hg) 77(73,80) 76.4(75,78) 77(76,78) 77(76,78) 78(76,79) 78(77,80) 0.37(-0.023,0.77)1 0.065 
Body mass index (kg/m2) 24.1(23.1,25.1) 23.5(23.14,23.78) 23.4(23.3,23.63) 23.5(23.3,23.8) 23. 5(23.1,23. 8) 23.8(23.4,24.3) 0.045(-0.062,0.15) 0.041 
Waist-to-hip ratio 0.93(0.91,0.95) 0.90(0.89,0.91) 0.90(0.90,0.90) 0.90(0.90,0.91) 0.91(0.90,0.91) 0.91(0.90,0.92) 0.0023(0.0000079,0.0045) 0.050 
Weight gain since 18 years (kg) 10.7(8.1,13.3) 10.7(9.9,11.6) 10.6(10.2,11.1) 10.2(9.6,10.8) 9.7(8.8,10.5) 11.3(10.2,12.4) -0.08(-0.4,0.2) 0.60 
Total cholesterol (mmol/L) 5.66(5.32,6.00) 5.56(5.45,5.67) 5.56(5.50,5.62) 5.49(5.41,5.56) 5.44(5.33,5.55) 5.54(5.40,5.68) -0.026(-0.063,0.011) 0.16 
Triglyceride (mmol/L) † 1.51(1.27,1.77) 1.36(1.30,1.45) 1.31(1.27,1.35) 1.34(1.28,1.38) 1.34(1.26,1.41) 1.35(1.26,1.43) -0.0039(-0.022,0.014) 0.67 
HDL-cholesterol (mmol/L) 1.56(1.45,1.67) 1.54(1.51,1.58) 1.59(1.57,1.61) 1.56(1.53,1.58) 1.57(1.53,1.60)1 1.55(1.51,1.60) -0.0025(-0.015,0.0095) 0.68 
LDL-cholesterol (mmol/L) 2.80(2.61,2.99) 2.86(2.80,2.92) 2.85(2.82,2.89) 2.80(2.76,2.84) 2.78(2.72,2.84) 2.85(2.78,2.93) -0.012(-0.033,0.0077) 0.23 
Glucose (mmol/L) † 6.11(5.76,6.55) 5.81(5.70,5.93) 5.81(5.76,5.87) 5.87(5.81,5.93) 5.87(5.70,5.99) 5.70(5.59,5.87) -0.0029(-0.0098,0.004) 0.41 
Values are means and prevalence (95% confidence intervals). All means, prevalence, regressions coefficients and odds ratios are age-adjusted, except for age. 
*Difference per increase of one birth: for continuous variables, regression coefficients of unit increase in the variables per increase of one birth; for 
dichotomous variables, odds ratio for increase in one birth. †Geometric means presented: regression coefficients represent increase in logged variable per 
increase of one birth. 
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Table 4 Association between MS and its component risk factors and pregnancies and births after fully adjusting confounders* in Chinese 
 Women Men 
 n† Difference per increase of 1 birth** P for trend n
† Difference per increase 
of 1 pregnancy** P for trend n
† Difference per increase of 1 birth** P for trend 









(-0.21, 0.65) 0.31 




(-0.039, 0.19) 0.20 
Waist-to-hip ratio 6914 0.0035 (0.0017, 0.0053) <0.001 6919
0.0026 
(0.0011, 0.0041) 0.001 3018
0.0016 
(-0.00089, 0.0040) 0.21 
Triglyceride‡ (mmol/L) 6925 0.017 (0.0024, 0.030) 0.021 6930
0.022 
(0.010, 0.034) <0.001 3025
-0.00031 
(-0.019, 0.019) 0.97 
HDL-cholesterol (mmol/L) 6925 -0.0042 (-0.014, 0.0055) 0.39 6930
-0.0084 
(-0.017, -0.00019) 0.045 3025
-0.00076 
(-0.012, 0.014) 0.91 
Glucose‡ (mmol/L) 6925 0.0069 (0.00052, 0.013) 0.034 6930
0.0042 
(-0.0013, 0.0096) 0.132 3025
-0.00025 
(-0.0078, 0.0073) 0.95 










*adjusted variables for women include: age, socioeconomic factors (education, occupation, house income and marital status), lifestyle factors (smoking, 
drinking and physical activity), reproduction associated factors (age at menarche, age at menopause, age at first pregnancy, use of contraceptive pills). Adjust 
variables for men include: age, socioeconomic factors (education, occupation, house income and marital status), lifestyle factors (smoking, drinking and 
physical activity). §Adjusted for the above factors and BMI.  †Number of participants with complete data on all variables included in the fully adjusted 
model. ‡Regression coefficients represent increase in logged variable per increase of one pregnancy or birth.  ** Difference per increase of one birth 
(pregnancy): for MS components, regression coefficients of unit increase in the variables per increase of one birth (pregnancy); for the MS, odds ratio for 
increase in one birth (pregnancy). 
 
Figure 1 Age-adjusted and fully-adjusted MS prevalence (95% confidence intervals) by births 
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